(AP) — Christopher B. Begley, chief executive of specialty drugmaker Hospira, received a 13 percent boost in compensation according to an analysis by the Associated Press. But most of that increase came in the form of stock options that have since lost value. Begley received a total ...
Copyright CRAIN - Crain's
